Editorial Commentary
Metabolomic profiling for predicting breast cancer treatment toxicities
Translational Cancer Research
2025;
14
(7)
:3883-3886
.
(30 July 2025)
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn
Translational Cancer Research
2025;
14
(7)
:3887-3891
.
(30 July 2025)
Limitations and oncological uncertainties of intraductal laser ablation for pathological nipple discharge
Translational Cancer Research
2025;
14
(7)
:3892-3893
.
(30 July 2025)
Unlocking the future of immunotherapy with circulating tumor DNA (ctDNA)-based liquid biopsy in non-small cell lung cancer
Translational Cancer Research
2025;
14
(7)
:3894-3898
.
(30 July 2025)
Women’s hormonal health research and care: the times, they are a-changin’
Translational Cancer Research
2025;
14
(7)
:3899-3904
.
(30 July 2025)
Original Article
TC2N promotes the proliferation and invasion of head and neck cancer cells with the p53-R175H
Translational Cancer Research
2025;
14
(7)
:3905-3919
.
(30 July 2025)
Integrative single-cell and bulk transcriptomic analyses identify a robust four-gene signature for risk stratification in neuroblastoma
Translational Cancer Research
2025;
14
(7)
:3920-3929
.
(30 July 2025)
The incidence, risk factors, and survival of acute myeloid leukemia secondary to chronic myelomonocytic leukemia: a population-based study
Translational Cancer Research
2025;
14
(7)
:3930-3942
.
(30 July 2025)
Identification and validation of hub genes for kidney renal clear cell carcinoma treated with metformin and everolimus combination therapy
Translational Cancer Research
2025;
14
(7)
:3943-3960
.
(30 July 2025)
First-line treatment of extensive-stage small cell lung cancer with immune checkpoint inhibitors acting on different targets: a systematic review and network meta-analysis
Translational Cancer Research
2025;
14
(7)
:3961-3972
.
(30 July 2025)
IL-6 promotes metastasis and EMT of non-small cell lung cancer cells by up-regulating FGL1 via STAT3 pathway
Translational Cancer Research
2025;
14
(7)
:3973-3990
.
(30 July 2025)
A novel fumaric acid metabolism-related prognostic signature associated with prognosis and immune infiltration landscape in laryngeal squamous cell carcinoma
Translational Cancer Research
2025;
14
(7)
:3991-4008
.
(30 July 2025)
Stemness-hypoxia genes PPARGC1A, PFKFB3, and SLC2A5 are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(7)
:4009-4023
.
(30 July 2025)
Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up?
Translational Cancer Research
2025;
14
(7)
:4024-4033
.
(30 July 2025)
Downregulation of ANKRD22 and its prognostic significance in squamous cell carcinoma of the cervix: a bioinformatics analysis based on public datasets
Translational Cancer Research
2025;
14
(7)
:4034-4045
.
(30 July 2025)
TSPAN9 inhibits malignant progression of hepatocellular carcinoma
Translational Cancer Research
2025;
14
(7)
:4046-4057
.
(30 July 2025)
Integrative analysis of CRISPR screening and gene expression data identifies a three-gene prognostic model associated with immune microenvironment in neuroblastoma
Translational Cancer Research
2025;
14
(7)
:4058-4070
.
(30 July 2025)
Association between real-time shear wave elastography findings and HER-2 expression in breast cancer
Translational Cancer Research
2025;
14
(7)
:4071-4079
.
(30 July 2025)
Integrating single-cell and bulk RNA sequencing data to construct a pyroptosis-related prognostic signature and analyze the tumor microenvironment in gastric cancer
Translational Cancer Research
2025;
14
(7)
:4080-4099
.
(30 July 2025)
Clinical value of SPP1 overexpression in patients with papillary thyroid carcinoma
Translational Cancer Research
2025;
14
(7)
:4100-4114
.
(30 July 2025)
Development of a quantitative genomic instability scoring system and a related competing endogenous RNA network in head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(7)
:4115-4141
.
(30 July 2025)
Survival outcomes of local versus radical resection for appendiceal neuroendocrine tumors: a population-based study
Translational Cancer Research
2025;
14
(7)
:4142-4159
.
(30 July 2025)
Construction and validation of an anoikis-related long non-coding RNA-based prognostic model for head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(7)
:4160-4178
.
(30 July 2025)
Prognostic implications of store-operated calcium entry signatures and immune dynamics in neuroblastoma via machine learning
Translational Cancer Research
2025;
14
(7)
:4179-4193
.
(30 July 2025)
Identification and validation of a novel signature based on M2 macrophage co-expressed genes in bladder cancer
Translational Cancer Research
2025;
14
(7)
:4194-4207
.
(30 July 2025)
Development and validation of machine learning models for classifying cancer-related sarcopenia using Kinect-based mixed-reality exercises in breast cancer survivors
Translational Cancer Research
2025;
14
(7)
:4208-4218
.
(30 July 2025)
Development of a prognostic model based on m6A reader HNRNPA2B1 upregulation and immune infiltration in multiple malignant tumors
Translational Cancer Research
2025;
14
(7)
:4219-4242
.
(30 July 2025)
A comparison of hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: a bioinformatics analysis
Translational Cancer Research
2025;
14
(7)
:4243-4259
.
(30 July 2025)
Clinical pathological characteristics correlation of H3F3A gene mutation in giant cell tumor of bone: a study of 96 cases
Translational Cancer Research
2025;
14
(7)
:4260-4278
.
(30 July 2025)
Correlation between the decreased expression of NUDT18 and tumor progression in endometrial cancer
Translational Cancer Research
2025;
14
(7)
:4279-4292
.
(30 July 2025)
Nicotine-induced PD-L1 expression in lung squamous cell carcinoma is mediated by the α7-nAChR/STAT3 signaling pathway
Translational Cancer Research
2025;
14
(7)
:4293-4304
.
(30 July 2025)
A nine-gene signature with potential targets for predicting the prognosis of patients with esophageal cancer
Translational Cancer Research
2025;
14
(7)
:4305-4320
.
(30 July 2025)
Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver
Translational Cancer Research
2025;
14
(7)
:4321-4330
.
(30 July 2025)
Construction and validation of an EGFR-related risk signature identified SHC1 as a prognostic biomarker for lung adenocarcinoma
Translational Cancer Research
2025;
14
(7)
:4331-4347
.
(30 July 2025)
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study
Translational Cancer Research
2025;
14
(7)
:4348-4356
.
(30 July 2025)
miR-490-5p inhibits the progression of osteosarcoma by targeting HDAC2
Translational Cancer Research
2025;
14
(7)
:4357-4368
.
(30 July 2025)
The safety and efficacy of NEPA in preventing postoperative nausea and vomiting after general anesthesia during gastrointestinal cancer surgery: a single-center retrospective study
Translational Cancer Research
2025;
14
(7)
:4369-4380
.
(30 July 2025)
Most eligible candidates for primary tumor resection among metastatic colorectal cancer patients: a SEER-based population analysis
Translational Cancer Research
2025;
14
(7)
:4381-4398
.
(30 July 2025)
Development and validation of a Hypoxia and Lactate Metabolism Prognostic Score (HLMPS) for breast cancer using machine learning
Translational Cancer Research
2025;
14
(7)
:4399-4415
.
(30 July 2025)
Family resilience and related influencing factors in Chinese patients with malignant spinal tumors: a cross-sectional study
Translational Cancer Research
2025;
14
(7)
:4416-4428
.
(30 July 2025)
Identification and validation of anoikis-related differentially expressed genes in nasopharyngeal carcinoma
Translational Cancer Research
2025;
14
(7)
:4429-4446
.
(30 July 2025)
Classification and influencing factors of family resilience and posttraumatic growth in patients with spinal tumor: a cross-sectional study
Translational Cancer Research
2025;
14
(7)
:4447-4460
.
(30 July 2025)
Review Article
Impact of smoking on the effectiveness of different non-small-cell lung cancer therapies
Translational Cancer Research
2025;
14
(7)
:4461-4473
.
(30 July 2025)
Erratum
Erratum: Long non-coding RNA SNHG17 promotes gastric cancer progression by inhibiting P15 and P16
Translational Cancer Research
2025;
14
(7)
:4474-4475
.
(30 July 2025)
Erratum: PA-MSHA exerts potent activity against cetuximab-resistant colorectal cancer through the miR-7-5p/Akt3/Wnt-β-catenin pathway
Translational Cancer Research
2025;
14
(7)
:4476-4478
.
(30 July 2025)
